Set at a wholesale acquisition cost (WAC) of $6,181.08 for two doses, which covers a four-week period, Celltrion stressed that it has strategically priced Zymfentra considering its new drug status, competitive market prices for inflammatory bowel disease (IBD) treatments, and the unique charact...